Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates | Zendy

C.-H. Lee | Zendy; L.-H. Su | Zendy; YaFen Tang | Zendy; J.-W. Liu | Zendy

Open Access

Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates

Author(s) -

C.-H. Lee,

L.-H. Su,

YaFen Tang,

J.-W. Liu

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl381

Subject(s) - klebsiella pneumoniae , microbiology and biotechnology , ertapenem , medicine , klebsiella , cephalosporin , meropenem , antibiotics , carbapenem , bacteremia , retrospective cohort study , biology , antibiotic resistance , escherichia coli , biochemistry , gene

To better understand the clinical outcomes of patients with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-KP) bacteraemia treated with either flomoxef or a carbapenem, and to evaluate the in vitro activities of these antibiotics against ESBL-KP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research